March 2007, Volume 37 Number 3 , p 67 - 67
SNOW, MICHELLE RN, BSN, MSHR, MSPH
Michelle Snow is working on her PhD in public health at the University of Utah in Salt Lake City.
GARDASIL, the first vaccine developed to protect girls and women from genital human papillomavirus (HPV), is now available. The vaccine prevents infection from four HPV types: HPV 6, 11, 16, and 18. These types are responsible for 70% of cervical cancers and 90% of genital warts. The Centers for Disease Control and Prevention (CDC) estimates that roughly 20 million men and women in the United States have genital HPV infections and that 6.2 million people acquire an HPV infection each year. 1
The Advisory Committee on Immunization Practices and the American Academy of Pediatrics recommend vaccination for girls and women ages 11 to 26 years, although the vaccine can be given to girls as young as age 9. Vaccination consists of 3 injections given over 6 months, with the second dose to be given 2 months after the first dose and the third dose given ...